| Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study A Fendler, L Au, STC Shepherd, F Byrne, M Cerrone, LA Boos, ... Nature Cancer 2 (12), 1321-1337, 2021 | 57 | 2021 |
| Clinical models to define response and survival with anti–PD-1 antibodies alone or combined with ipilimumab in metastatic melanoma I Pires da Silva, T Ahmed, JL McQuade, CA Nebhan, JJ Park, JM Versluis, ... Journal of Clinical Oncology 40 (10), 1068-1080, 2022 | 53 | 2022 |
| Characterization of the immune profile of oral tongue squamous cell carcinomas with advancing disease K Meehan, C Leslie, M Lucas, A Jacques, B Mirzai, J Lim, M Bulsara, ... Cancer Medicine 9 (13), 4791-4807, 2020 | 23 | 2020 |
| Individualizing systemic therapies in first line treatment and beyond for advanced renal cell carcinoma Y Khan, TD Slattery, LM Pickering Cancers 12 (12), 3750, 2020 | 12 | 2020 |
| Real-world outcomes with ipilimumab and nivolumab in advanced melanoma: a multicentre retrospective study P Serra-Bellver, JM Versluis, HK Oberoi, C Zhou, TD Slattery, Y Khan, ... European Journal of Cancer 176, 121-132, 2022 | 10 | 2022 |
| Adaptive immunity to SARS-CoV-2 in cancer patients: the CAPTURE study A Fendler, L Au, LA Boos, F Byrne, STC Shepherd, B Shum, CL Gerard, ... medRxiv, 2020.12. 21.20248608, 2020 | 4 | 2020 |
| Treatment and outcomes for synovial sarcoma patients in Western Australia: the role of neoadjuvant chemoradiotherapy Y Khan, R Carey‐Smith, M Taylor, J Woodhouse, A Jacques, D Wood, ... Cancer Reports 3 (6), e1268, 2020 | 1 | 2020 |
| Triple synchronous malignancies of the stomach, bladder and thyroid in a previously treated prostate cancer patient: A Case Report O Oey, SS Tiong, SL Wong, S Navadgi, Y Khan Folia Medica 65 (4), 693-698, 2023 | | 2023 |
| Stromal inflammation, fibrosis and cancer: An old intuition with promising potential O Oey, AF Sunjaya, Y Khan, A Redfern World Journal of Clinical Oncology 14 (7), 230, 2023 | | 2023 |
| Total neoadjuvant therapy for locally advanced rectal cancer: A western Australian experience. O Oey, A Khattak, T Ferguson, M Theophilus, SS Tiong, S Ali, Y Khan Journal of Clinical Oncology 41 (16_suppl), e15582-e15582, 2023 | | 2023 |
| 1106P International experience of ipilimumab and nivolumab in patients with advanced melanoma P Serra-Bellver, JM Versluis, HK Oberoi, TD Slattery, Y Khan, ... Annals of Oncology 31, S747-S748, 2020 | | 2020 |
| Adaptive immunity to SARS-CoV-2 in cancer patients: The CAPTURE study (preprint) A Fendler, L Au, LA Boos, F Byrne, STC Shepherd, B Shum, CL Gerard, ... | | 2020 |
| Analysis of 46,046 SARS-CoV-2 whole-genomes leveraging principal component analysis (PCA)(preprint) C Scherer, J Grover, D Kameraad, G Rudy, A Scherer, K Wu, TA McGrath, ... | | 2020 |
| Clinicopathological Characteristics and Outcomes for Oral Tongue Squamous Cell Carcinoma (OTSCC) at a Single Australian Institution Y Khan, A Jacques, P Friedland, C Sader, C Tang, C Meyer, J Dewar, ... Asia-Pacific Journal of Clinical Oncology 14, 62-62, 2018 | | 2018 |
| Delayed response to combination ipi/nivo in a patient with metastatic uveal melanoma (UM): a case report Y Khan, A Khan, E Gray, A McEvoy, MA Khattak | | |
| Prognostic role of peritoneal washing cytology at interval debulking surgery following neoadjuvant chemotherapy in ovarian cancer ND Palayoor, Y Khan, A Jacques, TM Meniawy | | |
Peter L FriedlandProfessor of Otolaryngology ,University of Western AustraliaVerified email at uwa.edu.au
